Proteina Co., Ltd.

We recognized early the importance of direct analysis of protein, since the product of a gene is inherently more complex and closer to function than the gene itself. This insight led to our founding as a biotechnology company.

PROTEINA developed the first-in-class Protein-Protein Interaction (PPI) analysis platform (“Single-Molecule Co-Immunoprecipitation Technology”) that enables quantitative PPI measurement at the single-molecule level. PROTEINA has accumulated extensive know-how in developing assays measuring the targeted PPI as well as the analytic capability to model the efficacy of a drug based on its PPI metrics.

Our mission is to analyze proteins in a new way, developing effective, new approaches to diagnosing disease and discovering new drug candidates, with our novel technology.

Primary focus
Location
Founded
2015
Website
proteina.co.kr
Business model
Protein category
Technology focus

Would you like to request an edit?
Send a message to [email protected]

Related alt protein companies

Protein Directory is brought to you in partnership with Bright Green Partners.
© Protein Directory. All rights reserved.